Summary

Digital Wound Care Management System Market Growth & Trends

The global digital wound care management system market size is expected to reach USD 6.2 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is driven by increasing technological advancements in digital wound care management solutions and growing awareness of their benefits. The aging population, which is at higher risk for diabetes and other chronic ailments, coupled with the rising global incidence of wounds and an increase in surgical procedures, is also fueling this growth. According to data from Healogics, LLC, approximately 34 million people in the United States are diagnosed with diabetes, with about 25% at risk of developing diabetic foot ulcers. Additionally, around 80% of lower extremity amputations are linked to prior foot ulcer incidents.

Advancements in AI-driven diagnostics and wearable device monitoring are further propelling market growth. Innovations in smart wound care and predictive analytics are improving treatment outcomes. For instance, in March 2024, Swift Medical received funding from DIGITAL, a leading digital technology innovation organization in Canada, to integrate AI into wound care, aiming to enhance patient outcomes. This initiative focuses on leveraging Swift Medical’s advanced AI technologies to refine and standardize wound care practices.

The global COVID-19 pandemic brought both challenges and opportunities for growth and innovation in healthcare, particularly in the development of virtual wound care solutions. These advancements have significantly improved healthcare delivery. For instance, the Home and Community Care Support Services Central East introduced the Wound Care Inter-professional Team (IPT), a multidisciplinary team dedicated to providing uninterrupted, high-quality wound care in patients' homes and communities throughout the pandemic. To support this innovative care model, Central East implemented Swift Medical's digital wound management platform, which enabled precise wound data collection and analysis in home settings and facilitated virtual consultations between clinicians and patients, enhancing care continuity.

Furthermore, key players in the market are adopting various strategies such as mergers and acquisitions, partnerships, collaborations, expansions, and new product launches to meet the evolving demands of end users and strengthen their market positions. For example, in April 2023, Swift Medical announced its participation in the Zebra PartnerConnect program, positioning itself as an Independent Software Vendor. This partnership integrates Swift Medical's digital wound management solution, Swift Skin and Wound, with Zebra's TC52ax mobile computers. The collaboration aims to extend healthcare providers' access to advanced wound care technologies, enhancing the quality of wound care while reducing costs.

Digital Wound Care Management System Market Report Highlights

• The software segment held the largest revenue share of 68.25% in 2023. The growth is driven by the increasing investment by market players in technological advancements in digital wound care management software.

• The chronic wounds segment held the largest market share of 53.96% in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2030. The segment growth is attributed to the rising prevalence of conditions like diabetes and vascular diseases.

• The hospital segment held the largest market share of 47.58% in 2023. The segment growth is attributed to the increasing demand for advanced wound care solutions in acute care settings.

• North America dominated the digital wound care management system market and accounted for the largest revenue share of 31.96% in 2023. The growth is attributed to the increasing awareness regarding the benefits associated with the adoption of digital wound care systems.

• Prominent players in the market are adopting various strategies such as product launches, collaborations, acquisitions, and mergers to expand their product portfolios and enhance their geographical presence.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Wound Type
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Wound Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Digital Wound Care Management System Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market Opportunity Analysis
3.2. Digital Wound Care Management System Market Analysis Tools
3.2.1. Industry Analysis - Porter’s Five Forces
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. Case Studies
3.2.4. COVID-19 Impact Analysis
Chapter 4. Digital Wound Care Management System Market: Product Estimates & Trend Analysis
4.1. Product Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Digital Wound Care Management System Market by Product Type Outlook
4.4. Software
4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
4.5. Hardware
4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Digital Wound Care Management System Market: Wound Type Estimates & Trend Analysis
5.1. Wound Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Digital Wound Care Management System Market by Wound Type Outlook
5.4. Chronic Wound
5.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.4.2. Diabetic Foot Ulcers
5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.4.3. Pressure Ulcer (PU)
5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.4.4. Venous Leg Ulcers
5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.4.5. Others
5.4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
5.5. Acute Wound
5.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 6. Digital Wound Care Management System Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Digital Wound Care Management System Market by End Use Outlook
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
6.5. Wound Care Clinics
6.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
6.6. Other
6.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 7. Digital Wound Care Management System Market: Regional Estimates & Trend Analysis, By Product, By Wound Type, By End Use
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Billion)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share/position analysis, 2023
8.4. Company Profiles
8.4.1. Healogics, LLC.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Technology Type benchmarking
8.4.1.4. Strategic initiatives
8.4.2. WoundZoom
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Technology Type benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Smith+Nephew
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Technology Type benchmarking
8.4.3.4. Strategic initiatives
8.4.4. WoundMatrix, Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Technology Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Healthy.io Ltd
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Technology Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Swift Medical Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Technology Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. eKare, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Technology Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Joerns Healthcare
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Technology Type benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Net Health Systems, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Technology Type benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Essity Aktiebolag (publ
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Technology Type benchmarking
8.4.10.4. Strategic initiatives
8.4.11. 3M
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Technology Type benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Entec Health Ltd.
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Technology Type benchmarking
8.4.12.4. Strategic initiatives
8.4.13. The Wound Pros, Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Technology Type benchmarking
8.4.13.4. Strategic initiatives
8.4.14. MolecuLight Inc.
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Technology Type benchmarking
8.4.14.4. Strategic initiatives
8.4.15. NATROX Wound Care (Inotec AMD Limited.)
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Technology Type benchmarking
8.4.15.4. Strategic initiatives